dexamethasone

Indications retained by WHO

Allergic or hypersensitivity conditions of unspecified type; Nausea or vomiting; Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy; Palliative care; Lymphoid leukaemia, not elsewhere classified, Plasma cell myeloma, Burkitt lymphoma including Burkitt leukaemia, Anaplastic large cell lymphoma, ALK-positive, Anaplastic large cell lymphoma, ALK-negative (complementary list).

Listed forms and strengths

• Oral > Liquid: 2 mg per 5 mL (as sodium phosphate)
• Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base)
• Oral > Solid > tablet: 4 mg (as dexamethasone base); 2 mg (as dexamethasone base)
• Oral > Liquid: 2 mg per 5 mL (as sodium phosphate); 0.5 mg per 5 mL (as sodium phosphate)
• Oral > Solid > tablet: 4 mg (as dexamethasone base); 2 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 0.5 mg (as dexamethasone base)
• Oral > Solid > tablet: 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 4 mg (as dexamethasone base); 2 mg (as dexamethasone base)
• Parenteral > General injections > unspecified: 4 mg per mL (dexamethasone phosphate (as sodium))
• Oral > Liquid: 0.5 mg per 5 mL (as sodium phosphate); 2 mg per 5 mL (as sodium phosphate)
• Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base)
• Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 0.5 mg (as dexamethasone base)
• Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base
• Oral > Solid > tablet: 4 mg (as dexamethasone base)
• Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base)
• Oral > Liquid: 2 mg per 5 mL
• Oral > Solid: 4 mg; 2 mg
• Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosophate salt)

Forms retained in the model list; presentations available in each country may differ.